ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,648Medicare Part D Prescriptions Filled, Including Refills

Rank: 286 out of 1206

$421K Total Retail Price of All Prescriptions

Rank: 258 out of 1206

336 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 336 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

22% of this provider’s 336 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 7,285 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
FUROSEMIDE 316 270 1 5
SIMVASTATIN 315 279 2 1
HYDROCODONE-ACETAMINOPHEN 299 225 S3 3 7
OMEPRAZOLE 283 264 4 3
WARFARIN SODIUM 271 253 5 8
LISINOPRIL 259 244 6 4
AMLODIPINE BESYLATE 254 235 7 6
FAMOTIDINE 237 182 8 65
LEVOTHYROXINE SODIUM 212 194 9 2
SERTRALINE HCL 208 180 10 22
POLYETHYLENE GLYCOL 3350 170 154 11 31
TRAMADOL HCL 137 126 12 17
POTASSIUM CHLORIDE 122 103 13 12
METFORMIN HCL 121 101 14 10
METOPROLOL SUCCINATE 118 118 15 15
METOPROLOL TARTRATE 117 117 16 9
HYDROCHLOROTHIAZIDE 115 100 17 11
NAMENDA 102 102 18 36
LANTUS 98 76 19 38
ATENOLOL 86 69 20 14
PREDNISONE 84 54 21 28
DONEPEZIL HCL 81 79 22 29
SUCRALFATE 77 75 23 143
ZOLPIDEM TARTRATE 76 35 24 25
TAMSULOSIN HCL 72 53 25 26
RISPERIDONE 72 70 25 74
CARVEDILOL 70 67 27 32
ATORVASTATIN CALCIUM 69 65 28 13
VESICARE 67 66 29 148
GLIMEPIRIDE 62 47 30 34
CITALOPRAM HBR 62 50 30 16
FLUTICASONE PROPIONATE 61 57 32 42
PANTOPRAZOLE SODIUM 59 49 33 54
DILTIAZEM 24HR ER 59 59 33 174
OXYCODONE HCL 59 12 S2 33 107
DIGOXIN 59 49 33 43
GABAPENTIN 58 47 37 18
NEXIUM 53 37 38 47
CRESTOR 51 39 39 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.